To investigate whether the inhibition of the tumour growth by ciglitazone was due to inhibition of proliferation, induction of apoptosis, or both, we analysed Ki67 expression and caspase 3 activation by immunohistochemistry (Figure 3C). The gene discussed is MKI67; the disease is neoplasm.